JPMorgan Dad Turns Biotech CEO in Disease Quest

JPMorgan Dad Turns Biotech CEO in Disease Quest Play

Feb. 20 (Bloomberg) -- Ilan Ganot, founder of Solid Ventures, talks about his decision to leave his career to create the biotechnology company after his son, Eytani, was diagnosed with Duchenne muscular dystrophy, a fatal genetic disease. Ganot, a former hedge fund specialist at JPMorgan Chase & Co., now aims to tackle the disease with a strategy he calls condition focus, a sole concentration on DMD. (Source: Bloomberg)

Feed Most Popular

  • On Air Now

    Encore: DELL Watch Now

  • Next

    2015 Surveillance

blog comments powered by Disqus